Search Result "ssr149415"
The Vasopressin V1b Receptor as a Therapeutic Target in Stress-related Disorders
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 2 Issue: 3 Year: 2003 Page: 191-200
Author(s): Guy Griebel, Jacques Simiand, Jeanne Stemmelin, Claudine Serradeil-Le Gal, Regis Steinberg
Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 1 Year: 2005 Page: 1549-1559
Author(s): Guy Griebel, Jeanne Stemmelin, Claudine Serradeil-Le Gal, Philippe Soubrie
Therapeutic Utilisations of Vasopressin and Oxytocin in Mood Disorders
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 1 Issue: 2 Year: 2007 Page: 157-161
Author(s): Gabrielle Scantamburlo, William Pitchot, Emmanuel Pinto, Marc Ansseau, Jean-Jacques Legros
Novel Non-Monoaminergic Antidepressants: Focus on Neuropeptides
Ebook: Frontiers in Drug Discovery
Volume: 2 Year: 2017
Author(s): Donatella Marazziti,Federico Mucci,Stefano Baroni,Liliana Dell`Osso
Doi: 10.2174/9781681084732117020013
The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 205-225
Author(s): Robert H. Ring
Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 3 Issue: 2 Year: 2008 Page: 77-93
Author(s): Neal G. Simon, Christophe Guillon, Karine Fabio, Ned D. Heindel, Shi-fang Lu, Marvin Miller, Craig F. Ferris, Michael J. Brownstein, Carrie Garripa, Gary A. Koppel
Vasopressin in Health and Disease with a Focus on Affective Disorders
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12 Issue: 4 Year: 2012 Page: 286-303
Author(s): Dora Zelena
The HPA Axis as Target for Depression
Journal: Current Neuropharmacology
Volume: 22 Issue: 5 Year: 2024 Page: 904-915
Author(s):
Non-Monoaminergic Targets for the Development of Antidepressants: Focus on Neuropeptides
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2013 Page: 2-10
Author(s): Mario Catena-DellâOsso,Andrea Fagiolini,Donatella Marazziti,Stefano Baroni,Cesario Bellantuono
Neuropeptides as Therapeutic Targets in Anxiety Disorders
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 3 Year: 2012 Page: 5709-5727
Author(s): En-Ju D. Lin